Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
28.80
+0.21 (0.73%)
At close: Nov 21, 2025, 4:00 PM EST
29.33
+0.53 (1.84%)
After-hours: Nov 21, 2025, 7:52 PM EST
Janux Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$77.40
Upside
+168.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| Barclays | Barclays | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +66.67% | Nov 7, 2025 |
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +63.19% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +247.22% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +56.25% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +150.00% | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +45.83% | Aug 19, 2025 |
| Raymond James | Raymond James | Buy Initiates $65 | Buy | Initiates | $65 | +125.69% | Jul 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +143.06% | Mar 3, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $62 → $41 | Hold | Maintains | $62 → $41 | +42.36% | Feb 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +594.44% | Dec 11, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $42 → $62 | Hold | Maintains | $42 → $62 | +115.28% | Dec 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $70 → $115 | Strong Buy | Maintains | $70 → $115 | +299.31% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $79 → $91 | Buy | Maintains | $79 → $91 | +215.97% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $70 | Strong Buy | Maintains | $63 → $70 | +143.06% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $79 | Buy | Initiates | $79 | +174.31% | Nov 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.